首页> 外文期刊>Research Journal of Biological Sciences >Comparative Assessment in Effectiveness of Levodopa and Levodopa plus Pramipexole (Restin) in Treatment of Patients with Parkinson ?s Disease Referred to Hospital
【24h】

Comparative Assessment in Effectiveness of Levodopa and Levodopa plus Pramipexole (Restin) in Treatment of Patients with Parkinson ?s Disease Referred to Hospital

机译:左旋多巴和左旋多巴联合普拉克索(瑞斯汀)治疗帕金森病的疗效比较评估

获取原文
       

摘要

One of the most common human neurodegenerative disorders, second only to Alzheimer disease, Parkinson Disease (PD) proves to be a diagnostic and therapeutic challenge in medical practice. Significant advances have been made in definin g its pathogenesis and pathology and in turn, in the development of therapeutic interventions designed to maximize control of symptoms while minimizing long-term disability and treatment related complications. The aim of this study was to comparative assessment in effectiveness of levodopa and levodopa plus restin in treatment of patients with Parkinson ?s disease referred to hospital. In this study, 40 patients with Parkinson disease were divided into 2 groups of 20. This study carried out from September until November, 2011 for 3 months. Based on data showed in the result, it has been revealed that combination use of levodopa plus restin showed better results than single use of levodopa. Finally can be state that the control of Parkinsonian symptoms in patients with dopamine agonists concomitant with levodopa therapy has been successful.
机译:帕金森病(PD)是仅次于阿尔茨海默病的最常见的人类神经退行性疾病之一,被证明是医学实践中的诊断和治疗挑战。在确定其发病机理和病理学方面,并进而在开发旨在最大程度地控制症状,同时将长期残疾和与治疗相关的并发症的可能性降至最低的治疗性干预措施方面,已经取得了重大进展。这项研究的目的是比较评估左旋多巴和左旋多巴加restin治疗帕金森氏病患者的有效性。在这项研究中,将40例帕金森病患者分为20组,每组20个。该研究从2011年9月至2011年11月进行了3个月。根据结果​​中显示的数据,已表明左旋多巴与restin的组合使用比单次使用左旋多巴显示出更好的结果。最后可以指出,在多巴胺激动剂与左旋多巴疗法同时进行的患者中,帕金森氏症的控制已获得成功。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号